Maze Therapeutics Inc. (MAZE)
NASDAQ: MAZE
· Real-Time Price · USD
13.39
0.04 (0.30%)
At close: Aug 15, 2025, 2:50 PM
13F Institute Ownership
Total Institutes of 64 in Maze Therapeutics expanded their positions with an increase of 64 investors compared to the previous quarter. An additional 35.63M shares, as total invested capital grew by $392.91M with ownership percentage increasing from 0.00% to 124.47%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Trv Gp Iv, LLC | 21.22% | 6.07M | +100.00% | 66.87M | 72.02% | May 09, 2025 |
| Frazier Life Sciences Manageme... | 14.42% | 4.13M | +100.00% | 45.46M | 2.08% | May 15, 2025 |
| Arch Venture Management, LLC | 14.39% | 4.12M | +100.00% | 45.36M | 22.00% | May 15, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.